巨春蓉, 韦兵, 练巧燕, 等. 实体器官移植术后巨细胞病毒肺炎的防治策略——ATS巨细胞病毒肺炎的诊治指南解读[J]. 器官移植, 2019, 10(1): 88-90. DOI: 10.3969/j.issn.1674-7445.2019.01.014
引用本文: 巨春蓉, 韦兵, 练巧燕, 等. 实体器官移植术后巨细胞病毒肺炎的防治策略——ATS巨细胞病毒肺炎的诊治指南解读[J]. 器官移植, 2019, 10(1): 88-90. DOI: 10.3969/j.issn.1674-7445.2019.01.014
shu
Ju Chunrong, Wei Bing, Lian Qiaoyan, et al. Prevention and treatment strategy of cytomegalovirus pneumonia after solid organ transplantation: interpretation of the diagnosis and treatment of ATS cytomegalovirus pneumonia[J]. ORGAN TRANSPLANTATION, 2019, 10(1): 88-90. DOI: 10.3969/j.issn.1674-7445.2019.01.014
Citation: Ju Chunrong, Wei Bing, Lian Qiaoyan, et al. Prevention and treatment strategy of cytomegalovirus pneumonia after solid organ transplantation: interpretation of the diagnosis and treatment of ATS cytomegalovirus pneumonia[J]. ORGAN TRANSPLANTATION, 2019, 10(1): 88-90. DOI: 10.3969/j.issn.1674-7445.2019.01.014
shu

实体器官移植术后巨细胞病毒肺炎的防治策略——ATS巨细胞病毒肺炎的诊治指南解读

Prevention and treatment strategy of cytomegalovirus pneumonia after solid organ transplantation: interpretation of the diagnosis and treatment of ATS cytomegalovirus pneumonia

    摘要
  • 摘要: 巨细胞病毒（CMV）肺炎是实体器官移植（SOT）受体最常见的感染性并发症之一，其中肺移植受体术后CMV肺炎的发生率明显高于其他SOT受体。CMV肺炎一旦发生，病情进展迅速、病死率高。针对CMV的预防性用药可以显著降低感染发生率及其相关病死率。本文根据2013年美国胸科学会（ATS）国际指南对CMV肺炎的高危因素、诊断标准及防治策略进行解读并综述。

     

    • HTML全文
    • 参考文献(18)
    • 相关文章
    • 施引文献
  • 资源附件(0)

/

返回文章
返回